Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1997-08-13
Original market date: See footnote 1
1994-12-31
Product name:
SEROMYCIN CAP 250MG
DIN:
02032414 Electronic product monograph is not available
Company:
ELI LILLY CANADA INC
SUITE 900
Exchange Tower, 130 King Street West
Toronto
Ontario
Canada
M5X 1B1
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:16.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
J04AB01 CYCLOSERINE
Active ingredient group (AIG) number:See footnote5
0105841001
Active ingredient(s) | Strength |
---|---|
CYCLOSERINE | 250 MG / CAP |